Amerena, John

A/Prof John Amerena

Cardiologist; Appoints at Medical School, Deakin University

More from this expert

SGLT2 inhibitors are rapidly becoming seen as cardiac drugs in their own right, above and beyond their role in diabetes.

Monographs iconMonographs